Clinical Trials - ABOS

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06511570A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy ParticipantsCOMPLETEDPHASE12024-06-252024-09-172024-09-17
NCT06335173A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)ACTIVE_NOT_RECRUITINGPHASE22024-02-292026-102026-10
NCT04931459A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild ADCOMPLETEDPHASE12021-06-212023-06-122023-06-12